Is Tyra Biosciences, Inc. (TYRA) Stock a Biotech Opportunity Ahead of Key SURF302 Trial Data?

TheFly reported connected June 17 that Oppenheimer initiated sum of TYRA with an Outperform standing and a $50 terms target. The steadfast highlighted TYRA's upcoming objective milestones, peculiarly the expected three-month implicit effect information from the SURF302 survey successful induction-refractory non-muscle invasive bladder cancer, anticipated successful August 2026. Following discussions with institution management, Oppenheimer expressed accrued assurance successful TYRA's outlook. The steadfast besides noted the company's beardown currency presumption of $383.5 million, expected to enactment operations into the 2nd fractional of 2028, portion viewing its oral attraction attack arsenic a imaginable vantage successful a illness country marked by repeated procedures and recurrence challenges.

Earlier connected May 13, Tyra Biosciences, Inc. (NASDAQ:TYRA) released its archetypal 4th 2026 fiscal results, reporting accrued concern successful objective improvement programs. Research and improvement expenses reached $33.5 cardinal for the 4th ended March 31, 2026, compared with $25.0 cardinal successful the prior-year period, chiefly owed to ongoing dabogratinib activities, including the BEACH301 and SURF302 trials and preparations for SURF303. General and administrative expenses roseate to $8.5 cardinal from $6.9 million, driven by higher personnel-related costs. The institution reported a first-quarter nett nonaccomplishment of $39.3 million, compared with a nett nonaccomplishment of $28.1 cardinal during the aforesaid play successful 2025.

Tyra Biosciences, Inc. (NASDAQ:TYRA) is simply a clinical-stage biotechnology institution processing precision medicines targeting FGFR biology to dainty crab and genetically defined diseases.

While we admit the imaginable of TYRA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.